• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索细胞因子输出在药物超敏反应伴嗜酸性粒细胞增多和全身症状(DRESS)诊断中的应用。

Exploring cytokine outputs for diagnostics in drug reaction with eosinophilia and systemic symptoms (DRESS).

作者信息

Copaescu Ana M, Mouhtouris Effie, James Fiona, Goh Michelle S Y, Phillips Elizabeth J, Trubiano Jason A

机构信息

Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.

Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.

出版信息

World Allergy Organ J. 2024 Dec 7;17(12):101002. doi: 10.1016/j.waojou.2024.101002. eCollection 2024 Dec.

DOI:10.1016/j.waojou.2024.101002
PMID:39717677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11665396/
Abstract

BACKGROUND

In an exploratory study to assess the potential to individualize T-cell diagnostics in antibiotic-associated severe T-cell mediated hypersensitivity, we focused on drug reaction with eosinophilia and systemic symptoms (DRESS) and the related cytokine outputs IL-4 and IL-5.

METHODS

Patients with well-phenotyped RegiSCAR ≥4 DRESS, positive intradermal skin testing, and a previous negative IFN-γ Enzyme-Linked ImmunoSpot (ELISpot) assay were prospectively recruited. We specifically performed an ELISpot assay with IL-4 and IL-5 cytokine outputs. As comparative controls, these cytokine outputs were performed simultaneously in patients with a positive IFN-γ release ELISpot result.

RESULTS

Four antibiotic-associated DRESS cases were included. The IL-4 and IL-5 output ELISpot assay demonstrated various results among these patients, with at least 1 cytokine present in all the cases. As for the 2 controls with known positive IFN-γ release, compared to the IFN-γ secretion, the cytokine output using IL-4 and IL-5 showed an increased positivity.

CONCLUSION

In patients where the early response has suggested a TH2 response such as DRESS, IL-4 and IL-5 cytokine outputs could present an investigational advantage, including when IFN-γ is negative. In the future, larger prospective studies are required to understand the role of varied cytokine outputs in T-cell-mediated hypersensitivities.

摘要

背景

在一项探索性研究中,为评估在抗生素相关严重T细胞介导的超敏反应中实现T细胞诊断个体化的潜力,我们聚焦于伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)以及相关的细胞因子IL-4和IL-5的产生情况。

方法

前瞻性招募了符合RegiSCAR标准且表现典型、DRESS评分≥4、皮内皮肤试验阳性且之前IFN-γ酶联免疫斑点试验(ELISpot)结果为阴性的患者。我们专门进行了检测IL-4和IL-5细胞因子产生情况的ELISpot试验。作为对照,在IFN-γ释放ELISpot结果为阳性的患者中同时进行这些细胞因子产生情况的检测。

结果

纳入了4例抗生素相关的DRESS病例。IL-4和IL-5产生情况的ELISpot试验在这些患者中显示出不同结果,所有病例中至少存在1种细胞因子。至于2例已知IFN-γ释放阳性的对照,与IFN-γ分泌情况相比,使用IL-4和IL-5检测细胞因子产生情况的阳性率更高。

结论

在早期反应提示为TH2反应的患者(如DRESS患者)中,IL-4和IL-5细胞因子产生情况可能具有研究优势,包括在IFN-γ为阴性时。未来,需要开展更大规模的前瞻性研究以了解不同细胞因子产生情况在T细胞介导的超敏反应中的作用。

相似文献

1
Exploring cytokine outputs for diagnostics in drug reaction with eosinophilia and systemic symptoms (DRESS).探索细胞因子输出在药物超敏反应伴嗜酸性粒细胞增多和全身症状(DRESS)诊断中的应用。
World Allergy Organ J. 2024 Dec 7;17(12):101002. doi: 10.1016/j.waojou.2024.101002. eCollection 2024 Dec.
2
Dose Dependent Antimicrobial Cellular Cytotoxicity-Implications for Diagnostics.剂量依赖性抗菌细胞毒性——对诊断的启示
Front Pharmacol. 2021 Aug 10;12:640012. doi: 10.3389/fphar.2021.640012. eCollection 2021.
3
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions.在严重迟发性免疫介导的抗生素药物不良反应中体内和体外诊断工具的作用。
J Allergy Clin Immunol Pract. 2021 May;9(5):2010-2015.e4. doi: 10.1016/j.jaip.2020.12.052. Epub 2021 Jan 13.
4
The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.体外 IFN-γ 释放酶联免疫斑点检测与体内皮肤试验联合应用于抗生素相关性严重皮肤不良反应患者。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1287-1296.e1. doi: 10.1016/j.jaip.2017.09.004. Epub 2017 Oct 31.
5
Skin-Homing IL-13-Producing T Cells Expand in the Circulation of Patients with Drug Rash with Eosinophilia and Systemic Symptoms.皮肤归巢的 IL-13 产生 T 细胞在药物引起的皮疹伴嗜酸性粒细胞增多和全身性症状患者的循环中扩增。
Dermatology. 2017;233(2-3):242-249. doi: 10.1159/000475546. Epub 2017 Jun 10.
6
Differential cytokine profiles produced by anti-epileptic drug re-exposure of peripheral blood mononuclear cells derived from severe anti-epileptic drug patients and non-allergic controls.由严重抗癫痫药物患者和非过敏对照者外周血单个核细胞抗癫痫药物再暴露产生的细胞因子谱的差异。
Cytokine. 2022 Sep;157:155951. doi: 10.1016/j.cyto.2022.155951. Epub 2022 Jun 27.
7
Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5(+) -associated coeliac disease.酶联免疫吸附试验检测干扰素 (IFN)-γ 和 IFN-γ 诱导蛋白-10 的离体全血分泌与 IFN-γ 酶联免疫斑点法一样敏感,可用于检测人类白细胞抗原 (HLA)-DQ2·5(+) 相关乳糜泻中对 gluten-reactive T 细胞。
Clin Exp Immunol. 2014 Feb;175(2):305-15. doi: 10.1111/cei.12232.
8
Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.使用活化细胞的新型干扰素-γ酶联免疫斑点试验用于鉴定引起超敏反应的药物元凶。
J Dermatol Sci. 2017 Jun;86(3):222-229. doi: 10.1016/j.jdermsci.2017.03.007. Epub 2017 Mar 14.
9
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome.新型靶向抑制白细胞介素-5 轴治疗药物反应伴嗜酸性粒细胞增多和全身性症状综合征。
Front Immunol. 2023 Apr 28;14:1134178. doi: 10.3389/fimmu.2023.1134178. eCollection 2023.
10
CTL ELISPOT Assay and T Cell Detection.CTL ELISPOT assay 和 T 细胞检测。
Methods Mol Biol. 2021;2325:65-77. doi: 10.1007/978-1-0716-1507-2_5.

引用本文的文献

1
Refining cytokine-based diagnostics in DRESS: A two-color IFN-γ/IL-4 ELISpot approach.优化药物超敏反应综合征中基于细胞因子的诊断方法:一种双色 IFN-γ/IL-4 酶联免疫斑点法。
World Allergy Organ J. 2025 Apr 3;18(4):101049. doi: 10.1016/j.waojou.2025.101049. eCollection 2025 Apr.

本文引用的文献

1
Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions.改善T细胞介导的药物不良反应诊断与管理的工具
Front Med (Lausanne). 2022 Oct 13;9:923991. doi: 10.3389/fmed.2022.923991. eCollection 2022.
2
Dose Dependent Antimicrobial Cellular Cytotoxicity-Implications for Diagnostics.剂量依赖性抗菌细胞毒性——对诊断的启示
Front Pharmacol. 2021 Aug 10;12:640012. doi: 10.3389/fphar.2021.640012. eCollection 2021.
3
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions.在严重迟发性免疫介导的抗生素药物不良反应中体内和体外诊断工具的作用。
J Allergy Clin Immunol Pract. 2021 May;9(5):2010-2015.e4. doi: 10.1016/j.jaip.2020.12.052. Epub 2021 Jan 13.
4
The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.体外 IFN-γ 释放酶联免疫斑点检测与体内皮肤试验联合应用于抗生素相关性严重皮肤不良反应患者。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1287-1296.e1. doi: 10.1016/j.jaip.2017.09.004. Epub 2017 Oct 31.
5
HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.HLA I类限制性CD8⁺T细胞和II类限制性CD4⁺T细胞与奈韦拉平超敏反应的发病机制有关。
AIDS. 2014 Aug 24;28(13):1891-901. doi: 10.1097/QAD.0000000000000345.
6
High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.在 HIV-1 感染期间,免疫选择后产生高亲合力、高 IFNγ 的 CD8 T 细胞反应。
Immunol Cell Biol. 2012 Feb;90(2):224-34. doi: 10.1038/icb.2011.34. Epub 2011 May 17.
7
Anti-IL-5 therapy and DRESS.抗白细胞介素-5疗法与药物超敏反应伴嗜酸性粒细胞增多和系统症状(DRESS)。
CMAJ. 2010 Jun 15;182(9):941. doi: 10.1503/cmaj.110-2054.
8
The role of cytokines in the mechanism of adverse drug reactions.细胞因子在药物不良反应机制中的作用。
Handb Exp Pharmacol. 2010(196):195-231. doi: 10.1007/978-3-642-00663-0_8.
9
Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions.严重全身性药物超敏反应后药物特异性T细胞的持久反应性和高频率
J Allergy Clin Immunol. 2006 Feb;117(2):455-62. doi: 10.1016/j.jaci.2005.10.030.